Frequency of Natural Regulatory CD4+CD25+ T Lymphocytes Determines the Outcome of Tolerance across Fully Mismatched MHC Barrier through Linked Recognition of Self and Allogeneic Stimuli

We show in this study that long-term tolerance to allogeneic skin grafts can be established in the absence of immunosuppression by the combination of the following elements: 1) augmenting the frequency of regulatory CD4(+)CD25(+) T cells (Treg) and 2) presentation of the allogeneic stimuli through l...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 176; no. 4; pp. 2324 - 2329
Main Authors Fucs, Rita, Jesus, Joszilene T, Souza Junior, Paulo H. N, Franco, Larissa, Vericimo, Mauricio, Bellio, Maria, Nobrega, Alberto
Format Journal Article
LanguageEnglish
Published United States Am Assoc Immnol 15.02.2006
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We show in this study that long-term tolerance to allogeneic skin grafts can be established in the absence of immunosuppression by the combination of the following elements: 1) augmenting the frequency of regulatory CD4(+)CD25(+) T cells (Treg) and 2) presentation of the allogeneic stimuli through linked recognition of allo- and self-epitopes on semiallogeneic F(1) APCs. BALB/c spleen cells enriched for CD4(+)CD25(+) T lymphocytes were transferred either to BALB/c nu/nu mice or to BALB/c nu/nu previously injected with F(1)(BALB/c x B6.Ba) spleen cells, or else grafted with F(1)(BALB/c x B6.Ba) skin (chimeric BALB/c nu/nu-F(1)). Chimeric BALB/c nu/nu-F(1) reconstituted with syngeneic CD25(+)-enriched spleen cells were unable to reject the previously transferred F(1)(BALB/c x B6.Ba) spleen cells or F(1)(BALB/c x B6.Ba) skin grafts, and a specific tolerance to a secondary B6 graft was obtained, with rejection of third-party CBA grafts. BALB/c nu/nu mice reconstituted only with syngeneic CD25(+)-enriched spleen cells rejected both B6 and CBA skin grafts. In contrast, when chimeric BALB/c nu/nu-F(1) were reconstituted with spleen populations comprising normal frequencies of Treg cells, the linked recognition of allo and self resulted in breaking of self tolerance and rejection of syngeneic grafts, strongly suggesting that linked recognition works in both directions, either to establish tolerance to allo, or to break tolerance to self, the critical parameter being the relative number of Treg cells.
AbstractList We show in this study that long-term tolerance to allogeneic skin grafts can be established in the absence of immunosuppression by the combination of the following elements: 1) augmenting the frequency of regulatory CD4(+)CD25(+) T cells (Treg) and 2) presentation of the allogeneic stimuli through linked recognition of allo- and self-epitopes on semiallogeneic F(1) APCs. BALB/c spleen cells enriched for CD4(+)CD25(+) T lymphocytes were transferred either to BALB/c nu/nu mice or to BALB/c nu/nu previously injected with F(1)(BALB/c x B6.Ba) spleen cells, or else grafted with F(1)(BALB/c x B6.Ba) skin (chimeric BALB/c nu/nu-F(1)). Chimeric BALB/c nu/nu-F(1) reconstituted with syngeneic CD25(+)-enriched spleen cells were unable to reject the previously transferred F(1)(BALB/c x B6.Ba) spleen cells or F(1)(BALB/c x B6.Ba) skin grafts, and a specific tolerance to a secondary B6 graft was obtained, with rejection of third-party CBA grafts. BALB/c nu/nu mice reconstituted only with syngeneic CD25(+)-enriched spleen cells rejected both B6 and CBA skin grafts. In contrast, when chimeric BALB/c nu/nu-F(1) were reconstituted with spleen populations comprising normal frequencies of Treg cells, the linked recognition of allo and self resulted in breaking of self tolerance and rejection of syngeneic grafts, strongly suggesting that linked recognition works in both directions, either to establish tolerance to allo, or to break tolerance to self, the critical parameter being the relative number of Treg cells.
Abstract We show in this study that long-term tolerance to allogeneic skin grafts can be established in the absence of immunosuppression by the combination of the following elements: 1) augmenting the frequency of regulatory CD4+CD25+ T cells (Treg) and 2) presentation of the allogeneic stimuli through linked recognition of allo- and self-epitopes on semiallogeneic F1 APCs. BALB/c spleen cells enriched for CD4+CD25+ T lymphocytes were transferred either to BALB/c nu/nu mice or to BALB/c nu/nu previously injected with F1(BALB/c × B6.Ba) spleen cells, or else grafted with F1(BALB/c × B6.Ba) skin (chimeric BALB/c nu/nu-F1). Chimeric BALB/c nu/nu-F1 reconstituted with syngeneic CD25+-enriched spleen cells were unable to reject the previously transferred F1(BALB/c × B6.Ba) spleen cells or F1(BALB/c × B6.Ba) skin grafts, and a specific tolerance to a secondary B6 graft was obtained, with rejection of third-party CBA grafts. BALB/c nu/nu mice reconstituted only with syngeneic CD25+-enriched spleen cells rejected both B6 and CBA skin grafts. In contrast, when chimeric BALB/c nu/nu-F1 were reconstituted with spleen populations comprising normal frequencies of Treg cells, the linked recognition of allo and self resulted in breaking of self tolerance and rejection of syngeneic grafts, strongly suggesting that linked recognition works in both directions, either to establish tolerance to allo, or to break tolerance to self, the critical parameter being the relative number of Treg cells.
Author Souza Junior, Paulo H. N
Jesus, Joszilene T
Bellio, Maria
Franco, Larissa
Fucs, Rita
Nobrega, Alberto
Vericimo, Mauricio
Author_xml – sequence: 1
  fullname: Fucs, Rita
– sequence: 2
  fullname: Jesus, Joszilene T
– sequence: 3
  fullname: Souza Junior, Paulo H. N
– sequence: 4
  fullname: Franco, Larissa
– sequence: 5
  fullname: Vericimo, Mauricio
– sequence: 6
  fullname: Bellio, Maria
– sequence: 7
  fullname: Nobrega, Alberto
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16455989$$D View this record in MEDLINE/PubMed
BookMark eNpNkV1v0zAUhi00xLrBL0BCvoKLKcXOh5NcjpQypI5JW7m2XOck8XDs4tiq8tP4d7i0CK58pPO8j-TzXqELYw0g9JaSZU7y-uOzGsdgrF7Ski3zZZql-Qu0oEVBEsYIu0ALQtI0idvyEl1N0zMhhJE0f4UuKcuLoq7qBfq1dvAzgJEzth3-JnxwQuNH6IMW3roZN6v8plmlxQ3e4s087gcrZw8TXoEHNyoTRz8Afghe2hGOkq3V4ISRgIV0dprwOmg943s1jcLLAVp8f9fgT8I5BS6GnQ39gDfK_IirR5C2N8ora46uJ9AdFqbFt1rbHgwoiZ-8GoNWr9HLTugJ3pzfa_R9_Xnb3CWbhy9fm9tNIjNKfFJTIiRAKWTJpIAUMkI7Uu4EFaWsIsLqsspSKNodrWtZyapjtagrIG0Facuya_T-5N07Gy81eT6qSYLWwoANE2clS0uSZxHMTuCfXzvo-N6pUbiZU8KPjfG_jfHYCc_5sbGYenfWh90I7b_MuaIIfDgBg-qHg3LA4x21jjjlh8PhP9VvBDumag
CitedBy_id crossref_primary_10_1097_01_tp_0000250731_44913_ee
crossref_primary_10_1111_j_1365_3083_2010_02461_x
crossref_primary_10_1111_j_1600_6143_2007_02088_x
crossref_primary_10_1016_j_smim_2011_08_012
crossref_primary_10_1016_j_trsl_2008_12_001
crossref_primary_10_1517_14728222_12_3_313
crossref_primary_10_1155_2013_852395
crossref_primary_10_3390_ijms18081753
crossref_primary_10_1111_jvh_12863
crossref_primary_10_3389_fimmu_2018_02875
crossref_primary_10_4049_jimmunol_1200190
crossref_primary_10_1016_j_humimm_2012_08_014
crossref_primary_10_1016_j_intimp_2006_07_019
crossref_primary_10_1007_s11596_013_1097_8
crossref_primary_10_1111_j_1365_2567_2008_02855_x
Cites_doi 10.4049/jimmunol.172.2.923
10.1182/blood-2003-04-1164
10.1016/S1074-7613(01)00120-0
10.1084/jem.161.1.72
10.1097/01.TP.0000106469.12073.01
10.1016/j.smim.2003.12.003
10.1111/j.1749-6632.1955.tb45955.x
10.1126/science.1082031
10.1073/pnas.0400084101
10.1046/j.1600-065X.2003.00078.x
10.4049/jimmunol.172.11.6539
10.1093/intimm/dxh122
10.1002/(SICI)1521-4141(200005)30:5<1255::AID-IMMU1255>3.0.CO;2-W
10.1097/01.TP.0000106471.23410.32
10.1016/j.coi.2004.01.004
10.1034/j.1600-065X.2001.1820107.x
10.1097/01.TP.0000106477.70852.29
10.1038/ni1077
10.1097/01.ASN.0000119575.98696.1D
10.4049/jimmunol.168.3.1069
10.1016/j.transproceed.2004.01.019
10.4049/jimmunol.156.10.3602
10.1097/01.TP.0000155179.61445.78
10.1126/science.8094901
10.1016/j.smim.2003.12.007
10.1038/nri1027
10.1097/01.TP.0000083043.84630.99
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.4049/jimmunol.176.4.2324
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 2329
ExternalDocumentID 10_4049_jimmunol_176_4_2324
16455989
www176_4_2324
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
08R
2WC
34G
39C
3O-
53G
55
5GY
5RE
5VS
79B
85S
8RP
AALRV
AARDX
ABEFU
ABFLS
ABOCM
ABPPZ
ABPTK
ACGFS
ACIWK
ACNCT
ACPRK
ADACO
ADBBV
ADKFC
AENEX
AETEA
AFFNX
AFRAH
AJYGW
ALMA_UNASSIGNED_HOLDINGS
BAWUL
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
FH7
FRP
G8K
GJ
GX1
H13
IH2
J5H
K-O
K78
KQ8
L7B
MVM
MYA
NEJ
O0-
OK1
P0W
P2P
PQEST
PQQKQ
R.V
RHF
RHI
RZQ
SJN
TWZ
WH7
WOQ
X
X7M
XJT
ZA5
ZE2
ZGI
---
-~X
.55
.GJ
18M
ABCQX
ABJNI
ACGFO
ADNWM
AFHIN
AFOSN
AHWXS
AIZAD
BTFSW
CGR
CUY
CVF
ECM
EIF
NPM
TR2
W8F
XSW
XTH
YHG
AAYXX
CITATION
7X8
ABDPE
ID FETCH-LOGICAL-c310t-910acee7ac76cae2e301f07ba1a7c8310697832e5db199c8c8f69a98e0d8e2d63
ISSN 0022-1767
IngestDate Fri Oct 25 23:45:56 EDT 2024
Thu Sep 26 18:30:17 EDT 2024
Sat Sep 28 08:38:42 EDT 2024
Tue Nov 10 19:50:37 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c310t-910acee7ac76cae2e301f07ba1a7c8310697832e5db199c8c8f69a98e0d8e2d63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://journals.aai.org/jimmunol/article-pdf/176/4/2324/1498205/2324.pdf
PMID 16455989
PQID 67627043
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_67627043
crossref_primary_10_4049_jimmunol_176_4_2324
pubmed_primary_16455989
highwire_smallpub1_www176_4_2324
ProviderPackageCode RHF
RHI
PublicationCentury 2000
PublicationDate 20060215
2006-Feb-15
2006-02-15
PublicationDateYYYYMMDD 2006-02-15
PublicationDate_xml – month: 02
  year: 2006
  text: 20060215
  day: 15
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 2006
Publisher Am Assoc Immnol
Publisher_xml – name: Am Assoc Immnol
References 2023010120181419400_R6
2023010120181419400_R7
2023010120181419400_R10
2023010120181419400_R8
2023010120181419400_R11
2023010120181419400_R9
2023010120181419400_R12
2023010120181419400_R13
2023010120181419400_R14
2023010120181419400_R15
2023010120181419400_R16
2023010120181419400_R17
2023010120181419400_R18
2023010120181419400_R19
2023010120181419400_R20
2023010120181419400_R21
2023010120181419400_R22
2023010120181419400_R23
2023010120181419400_R24
2023010120181419400_R25
2023010120181419400_R26
2023010120181419400_R27
2023010120181419400_R2
2023010120181419400_R3
2023010120181419400_R4
2023010120181419400_R5
2023010120181419400_R1
References_xml – ident: 2023010120181419400_R13
  doi: 10.4049/jimmunol.172.2.923
– ident: 2023010120181419400_R12
  doi: 10.1182/blood-2003-04-1164
– ident: 2023010120181419400_R10
  doi: 10.1016/S1074-7613(01)00120-0
– ident: 2023010120181419400_R16
  doi: 10.1084/jem.161.1.72
– ident: 2023010120181419400_R22
  doi: 10.1097/01.TP.0000106469.12073.01
– ident: 2023010120181419400_R2
  doi: 10.1016/j.smim.2003.12.003
– ident: 2023010120181419400_R17
  doi: 10.1111/j.1749-6632.1955.tb45955.x
– ident: 2023010120181419400_R3
  doi: 10.1126/science.1082031
– ident: 2023010120181419400_R25
  doi: 10.1073/pnas.0400084101
– ident: 2023010120181419400_R6
  doi: 10.1046/j.1600-065X.2003.00078.x
– ident: 2023010120181419400_R20
  doi: 10.4049/jimmunol.172.11.6539
– ident: 2023010120181419400_R24
  doi: 10.1093/intimm/dxh122
– ident: 2023010120181419400_R18
  doi: 10.1002/(SICI)1521-4141(200005)30:5<1255::AID-IMMU1255>3.0.CO;2-W
– ident: 2023010120181419400_R11
  doi: 10.1097/01.TP.0000106471.23410.32
– ident: 2023010120181419400_R1
  doi: 10.1016/j.coi.2004.01.004
– ident: 2023010120181419400_R4
  doi: 10.1034/j.1600-065X.2001.1820107.x
– ident: 2023010120181419400_R8
  doi: 10.1097/01.TP.0000106477.70852.29
– ident: 2023010120181419400_R19
  doi: 10.1038/ni1077
– ident: 2023010120181419400_R23
  doi: 10.1097/01.ASN.0000119575.98696.1D
– ident: 2023010120181419400_R27
  doi: 10.4049/jimmunol.168.3.1069
– ident: 2023010120181419400_R7
  doi: 10.1016/j.transproceed.2004.01.019
– ident: 2023010120181419400_R15
  doi: 10.4049/jimmunol.156.10.3602
– ident: 2023010120181419400_R26
  doi: 10.1097/01.TP.0000155179.61445.78
– ident: 2023010120181419400_R14
  doi: 10.1126/science.8094901
– ident: 2023010120181419400_R5
  doi: 10.1016/j.smim.2003.12.007
– ident: 2023010120181419400_R9
  doi: 10.1038/nri1027
– ident: 2023010120181419400_R21
  doi: 10.1097/01.TP.0000083043.84630.99
SSID ssj0006024
Score 1.9751006
Snippet We show in this study that long-term tolerance to allogeneic skin grafts can be established in the absence of immunosuppression by the combination of the...
Abstract We show in this study that long-term tolerance to allogeneic skin grafts can be established in the absence of immunosuppression by the combination of...
SourceID proquest
crossref
pubmed
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 2324
SubjectTerms Animals
Autoantigens - immunology
CD4-Positive T-Lymphocytes - immunology
Graft Survival - immunology
Histocompatibility Antigens - immunology
Immune Tolerance - immunology
Isoantigens - immunology
Mice
Phenotype
Receptors, Interleukin-2 - immunology
Skin Transplantation - immunology
Spleen - immunology
Transplantation, Homologous - immunology
Title Frequency of Natural Regulatory CD4+CD25+ T Lymphocytes Determines the Outcome of Tolerance across Fully Mismatched MHC Barrier through Linked Recognition of Self and Allogeneic Stimuli
URI http://www.jimmunol.org/cgi/content/abstract/176/4/2324
https://www.ncbi.nlm.nih.gov/pubmed/16455989
https://search.proquest.com/docview/67627043
Volume 176
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9pAEF4lqVr1pWrTi5770KgPrh1jjI_HBEopKqmUEok3a1mvJSRjR2ALwT_rv-vM7hoblKrHi4UsNBjPfHPsXIR8CGJwM7zANv2kE5tuYs_MkHFusgDMXxCEScfD5uTxlTe8cUfT7vTo-GOjaqksZhbf3tlX8j9chXvAV-yS_QfO7ojCDfgM_IUrcBiuf8XjwVIVQsss-RVTIzSu1XZ5zJ33-u6Zc9nr4-6hS2NifNsA73K-wbPWvq6DwREPICrfywKeUB4gTPJULFUngbShskBkY4znK_BugcexMR7KRIVcdlct-sGgVmCvoy5IUn7oD5EmMj9xkYKSBb065-DfzrEmq-kW1w1qaoYFNq2o4VBnMgVnNw4sBqUqbbqeFzuTMhKrskpobEHPgedcD5_Myy0zRmU2VycTWAuZG0OrTkLJ5SK56hIHnbdih0chjqmaQXX3gZJp4-tikeVpU-1DxN321d4PS2hN34W42bO9PVOgdtFomXebir2jWr0PLY4LERZaHP1iLKBgudbht0FsbhdSCCE6xZH4YW1-q5KDA6u8q5Vcr9dANHIjJHpM7jmgUbF28cu0rmXybMetxuLj_1TjtfDZzu94MhyUqx9j3xurJmT_PtqSXtfkMXmkZYJeKNl_Qo5EdkruqwWqm1PyYKxLQ56Snzsw0DyhGgy0BgMFMBgIBYNOaAMItAYCBSBQDQQksgMCVUCgEgi0BgIFIFANBKqBQBUQaAMISAuBQAEItAYC1UB4Rm4Gnye9oan3kpgcgqEC_AObgW_pM-57nAlHgJFMbH_G2sznuLjPw_NUR3TjWTsMecCDxAtZGAg7DoQTe53n5CTLM_GSUBZ6DgsTh9s8ceMwDrouZ-Dk220uutwNW-RTxZ_oVo2fiSBsR85GFWejWjxahFY8jOBVpCnwrh3tSVCLvK94G4ElwfQgy0ReriIP_CLfdjst8kKxvP5FLS2v_kz-NXlYI_MNOSmWpXgLbnsxeydF9hd7Vu-O
link.rule.ids 315,783,787,27938,27939
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Frequency+of+Natural+Regulatory+CD4%2BCD25%2B+T+Lymphocytes+Determines+the+Outcome+of+Tolerance+across+Fully+Mismatched+MHC+Barrier+through+Linked+Recognition+of+Self+and+Allogeneic+Stimuli&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Fucs%2C+Rita&rft.au=Jesus%2C+Joszilene+T&rft.au=Souza+Junior%2C+Paulo+H.+N&rft.au=Franco%2C+Larissa&rft.date=2006-02-15&rft.pub=Am+Assoc+Immnol&rft.issn=0022-1767&rft.eissn=1550-6606&rft.volume=176&rft.issue=4&rft.spage=2324&rft_id=info:doi/10.4049%2Fjimmunol.176.4.2324&rft_id=info%3Apmid%2F16455989&rft.externalDBID=n%2Fa&rft.externalDocID=www176_4_2324
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon